Barnie Ramachandran
About Barnie Ramachandran
Barnie Ramachandran serves as the Global Head of Safety and Pharmacovigilance at Amylyx Pharmaceuticals, bringing over 15 years of experience in managing pharmacovigilance operations and medical safety for drugs and biologics.
Work at Amylyx Pharmaceuticals
Barnie Ramachandran serves as the Global Head of Safety and Pharmacovigilance at Amylyx Pharmaceuticals. He has held this position since 2023. In this role, he is responsible for overseeing the safety and pharmacovigilance operations within the organization, ensuring compliance with regulatory standards and managing the safety profile of the company's products.
Education and Expertise
Barnie Ramachandran earned his Medical Doctor (M.D.) degree from Medical Academy, where he studied General Medicine. He also holds a Master of Public Health (MPH) in Epidemiology from the University of North Carolina at Chapel Hill. His educational background supports his extensive expertise in pharmacovigilance and medical safety.
Background in Pharmacovigilance
With over 15 years of experience in pharmacovigilance operations, Barnie Ramachandran has a proven track record in managing medical safety for both drugs and biologics. He has built and led pharmacovigilance teams and has experience managing safety across all stages of the product life cycle development.
Previous Experience in the Pharmaceutical Industry
Before joining Amylyx Pharmaceuticals, Barnie Ramachandran worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Medical Safety Lead for the Janssen COVID-19 Vaccine and Immunology from 2013 to 2022. He also held positions at Apotex Inc. as Project Leader in Global Pharmacovigilance and at BeiGene as Executive Medical Director. His diverse experience spans various roles in the pharmaceutical industry.
Leadership in Medical Safety
Throughout his career, Barnie Ramachandran has demonstrated leadership in medical safety activities. His role as Medical Safety Officer for the Janssen COVID-19 Vaccine involved critical oversight during a significant public health initiative. His leadership skills have been instrumental in ensuring the safety and efficacy of multiple blockbuster drugs.